Emodin Promotes Peripheral Nerve Repair by Modulating Inflammasome Activation Through Autophagy via the

Zhengyang Long1,2,3,4, Yixun Huang1,2,3,4, Tao Lin1,2,3,4

  • 1Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

PubMed

Insights

Emodin promotes nerve regeneration after injury by enhancing autophagy, reducing inflammation, and activating the EGFR/PI3K/Akt/mTOR pathway. This natural compound aids functional recovery and reduces muscle atrophy, offering potential therapeutic benefits for peripheral nerve injury.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Regenerative Medicine

Background:

  • Peripheral nerve injury (PNI) leads to significant functional deficits.
  • Current treatments for PNI have limitations in promoting complete nerve regeneration.
  • Understanding molecular mechanisms underlying nerve repair is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate emodin's potential to promote nerve regeneration following PNI.
  • To elucidate the molecular targets of emodin, including macrophage polarization, NLRP3 inflammasome, autophagy, and the EGFR/PI3K/Akt/mTOR pathway.

Main Methods:

  • Sciatic nerve injury model in Sprague-Dawley rats.
  • Treatment groups included emodin, MCC950, rapamycin, 3-MA, and NSC 228155.
  • Assessment of nerve regeneration and function via histology, immunofluorescence, TEM, SFI, and Western blot.

Main Results:

  • Emodin enhanced axonal and myelin regeneration, reduced muscle atrophy and collagen deposition.
  • Emodin modulated macrophage polarization towards M2 phenotype, inhibited NLRP3 inflammasome, and activated autophagy in Schwann cells.
  • Network pharmacology identified EGFR as a key target, with emodin inhibiting its activation within the PI3K/AKT/mTOR pathway.

Conclusions:

  • Emodin promotes early nerve recovery and functional improvement after PNI.
  • Emodin's therapeutic effects involve boosting autophagy, inhibiting NLRP3 inflammasome, promoting M2 macrophage polarization, and modulating the EGFR/PI3K/AKT/mTOR pathway.